We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

214 hedge funds and large institutions have $1.82B invested in Beam Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $7.11M

18% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 62

8.14% more ownership

Funds ownership: 86.14% → 94.28% (+8.1%)

3% less funds holding

Funds holding: 221 → 214 (-7)

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

22% less capital invested

Capital invested by funds: $2.32B → $1.82B (-$504M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
214
Holders Change
-7
Holders Change %
-3.17%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
36
Increased
73
Reduced
62
Closed
41
Calls
$16.6M
Puts
$7.11M
Net Calls
+$9.45M
Net Calls Change
+$24.8M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$134M
2
FCM
Farallon Capital Management
California
+$83.5M
3
First Trust Advisors
First Trust Advisors
Illinois
+$36.4M
4
BlackRock
BlackRock
New York
+$22.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$19.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$81.5M
2
DGM
Darwin Global Management
Jersey
-$70M
3
AIM
ARK Investment Management
Florida
-$13.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$12M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFFP
201
Center for Financial Planning
Michigan
$1.17K – – –
AA
202
Ancora Advisors
Ohio
$1.17K – – –
PSB
203
Piscataqua Savings Bank
New Hampshire
$1.17K – – –
FFA
204
Farther Finance Advisors
California
$1.06K -$98 -4 -8%
RIL
205
Rothschild Investment LLC
Illinois
$820 +$737 +30 +600%
LFG
206
Larson Financial Group
Missouri
$703 – – –
HCM
207
Hollencrest Capital Management
California
$609 – – –
BIA
208
Bell Investment Advisors
California
$539 – – –
CFO
209
CVA Family Office
Colorado
$515 +$540 +22 New
GWP
210
Gen-Wealth Partners
Michigan
$422 – – –
CMBA
211
C.M. Bidwell & Associates
Hawaii
$351 – – –
JWA
212
JFS Wealth Advisors
Pennsylvania
$329 +$344 +14 New
BWL
213
Bogart Wealth LLC
Virginia
$258 – – –
SIC
214
SJS Investment Consulting
Ohio
$47 +$49 +2 New
DGM
215
Darwin Global Management
Jersey
– -$70M -2,119,598 Closed
JFG
216
Jefferies Financial Group
New York
– -$6.44M -195,000 Closed
CSS
217
Cubist Systematic Strategies
Connecticut
– -$2.68M -81,220 Closed
State of New Jersey Common Pension Fund D
218
State of New Jersey Common Pension Fund D
New Jersey
– -$2.57M -77,880 Closed
PP
219
PDT Partners
New York
– -$1.84M -55,649 Closed
PHK
220
Point72 Hong Kong
Hong Kong
– -$1.6M -48,325 Closed
HF
221
HRT Financial
New York
– -$1.25M -37,955 Closed
AIG
222
American International Group
New York
– -$1.21M -36,760 Closed
TC
223
TwinBeech Capital
New York
– -$1.14M -34,641 Closed
DTL
224
Dynamic Technology Lab
Singapore
– -$998K -30,196 Closed
BAMCO Inc
225
BAMCO Inc
New York
– -$991K -30,000 Closed
7 8
9
10 11

BEAM Hedge Fund Activity: Q2 2024 in Review

214 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2024, worth a combined $1.82B — down 22% from $2.32B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of BEAM and 36 opened new positions — a net loss of 5 holders — while 62 trimmed existing stakes and 73 added.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $134M. The largest seller was Morgan Stanley, cutting an estimated $81.5M.

  • 214 institutional investors held Beam Therapeutics (BEAM) as of Q2 2024, down from 221 in Q1 2024.
  • Funds reported $1.82B of Beam Therapeutics stock for Q2 2024, down 22% quarter-over-quarter.
  • 36 funds opened new Beam Therapeutics positions in Q2 2024 and 41 closed out, a net change of -5 holders.
  • The largest Beam Therapeutics buyer in Q2 2024 was Arch Venture Management, an estimated $134M added.
  • The largest Beam Therapeutics seller in Q2 2024 was Morgan Stanley, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2024.